GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Concord Biotech Ltd

Concord Biotech Allots 104.6 Million Bonus Shares

BONUS ▲ Positive Development LOW RISK
📅 Filed on BSE: 05 Nov 2026, 06:03 PM IST  ·  BSE ID: c3d4f292-dbcd-4225-af99-a86fe661a366
View Original BSE Filing (PDF)
💡
In Simple Terms
Concord Biotech gave eligible shareholders one new free share for every share they already owned.
🤖 AI Summary
  • Concord Biotech allotted 104,616,204 bonus equity shares on November 5, 2026.
  • The bonus issuance was at a 1:1 ratio for existing shareholders.
  • The company's paid-up share capital increased to Rs. 20,92,32,408.
  • Shareholders of record on November 4, 2026, were eligible for the bonus shares.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Bonus Equity Shares Allotted
10,46,16,204
Bonus Ratio
1 (One) equity share for every 1 (One) existing equity share
Face Value per Share
Rs. 1/-
Record Date
Wednesday, November 04, 2026
New Paid-up Share Capital
Rs. 20,92,32,408/-
Total Equity Shares Post-Allotment
20,92,32,408
🏢 How This Affects the Company
💰
Financial Impact
The company's paid-up share capital has doubled, increasing the equity base without additional cash inflow from shareholders.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders. Bonus shares have been automatically credited to eligible demat accounts.
👤
Who Is Affected
All shareholders whose names appeared in the company's register of members on November 4, 2026, received bonus shares.
🔍
Management Signal
This signals management's intent to reward shareholders by capitalizing retained earnings into equity.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Update on total outstanding shares in shareholding pattern filing.
Review of Q3 FY27 results for financial performance post-bonus issue.
Management commentary on capital allocation strategy in future investor calls.
LOW RISK Routine bonus share allotment confirming prior announcement; no new material risks introduced.
💡 Investor Takeaway
Concord Biotech allotted 104,616,204 bonus shares at a 1:1 ratio, increasing paid-up share capital to Rs. 20,92,32,408.
⚖️ Strengths & Concerns

✅ Positives

  • Company successfully executed 1:1 bonus share issuance, increasing equity shares to 10,46,16,204.

⚠️ Concerns

  • Paid-up share capital increased to Rs. 20,92,32,408 post-allotment, reflecting dilution per share.
📅 Company Track Record
Concord Biotech had previously set November 4, 2026, as the record date for a 1:1 bonus share issuance.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
How many bonus equity shares did Concord Biotech allot?
Concord Biotech allotted 10,46,16,204 fully paid-up bonus equity shares on November 5, 2026.
What was the bonus share ratio for Concord Biotech?
The bonus ratio was 1 (One) equity share for every 1 (One) existing fully paid-up equity share.
What is the new paid-up share capital of Concord Biotech?
Consequent to the allotment, the paid-up share capital stands increased to Rs. 20,92,32,408/-.
Who was eligible to receive the bonus shares from Concord Biotech?
Eligible shareholders were those whose names appeared in the register of members on the record date, November 4, 2026.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.